Zoetis Inc. Class A (NYSE: ZTS) stock closed at 186.6 per share at the end of the most recent trading day (a 0.65% change compared to the prior day closing price) with a volume of 1.98M shares and market capitalization of 88.56B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Drug Manufacturers industry, Healthcare sector and employs 11300 people. Zoetis Inc. Class A CEO is Kristin C. Peck.

The one-year performance of Zoetis Inc. Class A stock is 36.21%, while year-to-date (YTD) performance is 12.75%. ZTS stock has a five-year performance of 295.08%. Its 52-week range is between 131.28 and 187.32, which gives ZTS stock a 52-week price range ratio of 98.59%

Zoetis Inc. Class A currently has a PE ratio of 50.00, a price-to-book (PB) ratio of 21.53, a price-to-sale (PS) ratio of 12.63, a price to cashflow ratio of 41.90, a PEG ratio of 2.32, a ROA of 13.62%, a ROC of 18.82% and a ROE of 50.56%. The company’s profit margin is 25.28%, its EBITDA margin is 40.80%, and its revenue ttm is $7.01 Billion , which makes it $14.77 revenue per share.

Of the last four earnings reports from Zoetis Inc. Class A, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $1.07 for the next earnings report. Zoetis Inc. Class A’s next earnings report date is 05th Aug 2021.

The consensus rating of Wall Street analysts for Zoetis Inc. Class A is Moderate Buy (1.93), with a target price of $186.75, which is +0.12% compared to the current price. The earnings rating for Zoetis Inc. Class A stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Zoetis Inc. Class A has a dividend yield of 0.54% with a dividend per share of $1.00 and a payout ratio of 23.00%.

Zoetis Inc. Class A has a Buy technical analysis rating based on Technical Indicators (ADX : 9.23, ATR14 : 3.20, CCI20 : 111.24, Chaikin Money Flow : 0.07, MACD : 3.91, Money Flow Index : 68.94, ROC : 7.35, RSI : 69.18, STOCH (14,3) : 95.34, STOCH RSI : 0.35, UO : 66.94, Williams %R : -4.66), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Zoetis Inc. Class A in the last 12-months were: Catherine A. Knupp (Option Excercise at a value of $0), Catherine A. Knupp (Sold 21 283 shares of value $3 516 010 ), Frank A. D'Amelio (Option Excercise at a value of $0), Glenn David (Option Excercise at a value of $1 925 113), Glenn David (Sold 26 285 shares of value $4 439 964 ), Gregory Norden (Option Excercise at a value of $0), Heidi C. Chen (Option Excercise at a value of $1 543 927), Heidi C. Chen (Sold 29 192 shares of value $4 946 073 ), James Michael McFarland (Option Excercise at a value of $0), Juan Ramon Alaix (Option Excercise at a value of $9 746 047), Juan Ramon Alaix (Sold 224 817 shares of value $36 544 534 ), Kristin C. Peck (Option Excercise at a value of $1 142 930), Kristin C. Peck (Sold 51 927 shares of value $8 496 201 ), Linda Rhodes (Option Excercise at a value of $0), Linda Rhodes (Sold 1 087 shares of value $173 007 ), Louise M. Parent (Option Excercise at a value of $0), Michael B. McCallister (Option Excercise at a value of $0), Paul M. Bisaro (Option Excercise at a value of $0), Robert Edward Kelly (Option Excercise at a value of $175 402), Robert Edward Kelly (Sold 8 217 shares of value $1 335 260 ), Robert W Scully (Buy at a value of $1 249 931), Robert W Scully (Option Excercise at a value of $0), Roman Trawicki (Option Excercise at a value of $705 613), Roman Trawicki (Sold 14 481 shares of value $2 240 670 ), Roxanne Lagano (Option Excercise at a value of $1 065 095), Roxanne Lagano (Sold 24 000 shares of value $3 968 160 ), Sanjay Khosla (Option Excercise at a value of $0), William C. Steere (Option Excercise at a value of $0), Willie M. Reed (Option Excercise at a value of $0), Willie M. Reed (Sold 3 770 shares of value $599 694 )